Logo image of LSAK

LESAKA TECHNOLOGIES INC (LSAK) Stock Fundamental Analysis

USA - NASDAQ:LSAK - US64107N2062 - Common Stock

4.35 USD
0 (0%)
Last: 10/27/2025, 6:42:04 PM
4.18 USD
-0.17 (-3.91%)
After Hours: 10/27/2025, 6:42:04 PM
Fundamental Rating

2

Taking everything into account, LSAK scores 2 out of 10 in our fundamental rating. LSAK was compared to 99 industry peers in the Financial Services industry. Both the profitability and financial health of LSAK have multiple concerns. LSAK has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year LSAK has reported negative net income.
LSAK had a positive operating cash flow in the past year.
In the past 5 years LSAK always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: LSAK reported negative operating cash flow in multiple years.
LSAK Yearly Net Income VS EBIT VS OCF VS FCFLSAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

LSAK has a Return On Assets of -9.48%. This is amonst the worse of the industry: LSAK underperforms 87.88% of its industry peers.
LSAK's Return On Equity of -33.22% is on the low side compared to the rest of the industry. LSAK is outperformed by 87.88% of its industry peers.
With a Return On Invested Capital value of 0.94%, LSAK perfoms like the industry average, outperforming 41.41% of the companies in the same industry.
Industry RankSector Rank
ROA -9.48%
ROE -33.22%
ROIC 0.94%
ROA(3y)-5.38%
ROA(5y)-8.38%
ROE(3y)-15.9%
ROE(5y)-17.57%
ROIC(3y)N/A
ROIC(5y)N/A
LSAK Yearly ROA, ROE, ROICLSAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Operating Margin of LSAK (1.07%) is worse than 72.73% of its industry peers.
Looking at the Gross Margin, with a value of 27.45%, LSAK is in line with its industry, outperforming 46.46% of the companies in the same industry.
In the last couple of years the Gross Margin of LSAK has remained more or less at the same level.
Industry RankSector Rank
OM 1.07%
PM (TTM) N/A
GM 27.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.52%
GM growth 5Y-1.06%
LSAK Yearly Profit, Operating, Gross MarginsLSAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

LSAK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for LSAK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LSAK Yearly Shares OutstandingLSAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
LSAK Yearly Total Debt VS Total AssetsLSAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 2.03 indicates that LSAK is not a great score, but indicates only limited risk for bankruptcy at the moment.
LSAK's Altman-Z score of 2.03 is fine compared to the rest of the industry. LSAK outperforms 76.77% of its industry peers.
A Debt/Equity ratio of 1.03 is on the high side and indicates that LSAK has dependencies on debt financing.
LSAK's Debt to Equity ratio of 1.03 is in line compared to the rest of the industry. LSAK outperforms 43.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z 2.03
ROIC/WACC0.07
WACC12.64%
LSAK Yearly LT Debt VS Equity VS FCFLSAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

LSAK has a Current Ratio of 1.37. This is a normal value and indicates that LSAK is financially healthy and should not expect problems in meeting its short term obligations.
LSAK has a better Current ratio (1.37) than 61.62% of its industry peers.
LSAK has a Quick Ratio of 1.25. This is a normal value and indicates that LSAK is financially healthy and should not expect problems in meeting its short term obligations.
LSAK has a Quick ratio (1.25) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.25
LSAK Yearly Current Assets VS Current LiabilitesLSAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.56% over the past year.
EPS 1Y (TTM)55.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%58.63%

3.2 Future

Based on estimates for the next years, LSAK will show a very strong growth in Earnings Per Share. The EPS will grow by 51.03% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y329.5%
EPS Next 2Y78.61%
EPS Next 3Y51.03%
EPS Next 5YN/A
Revenue Next Year13.32%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LSAK Yearly Revenue VS EstimatesLSAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
LSAK Yearly EPS VS EstimatesLSAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LSAK. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 15.80, which indicates a correct valuation of LSAK.
LSAK's Price/Forward Earnings ratio is in line with the industry average.
LSAK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 15.8
LSAK Price Earnings VS Forward Price EarningsLSAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LSAK is valued a bit cheaper than 61.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.82
LSAK Per share dataLSAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

LSAK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LSAK's earnings are expected to grow with 51.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y78.61%
EPS Next 3Y51.03%

0

5. Dividend

5.1 Amount

LSAK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LESAKA TECHNOLOGIES INC

NASDAQ:LSAK (10/27/2025, 6:42:04 PM)

After market: 4.18 -0.17 (-3.91%)

4.35

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)09-10 2025-09-10/amc
Earnings (Next)11-05 2025-11-05
Inst Owners42.61%
Inst Owner ChangeN/A
Ins Owners3.9%
Ins Owner Change0%
Market Cap363.96M
Revenue(TTM)N/A
Net Income(TTM)-61530000
Analysts82.86
Price Target8.16 (87.59%)
Short Float %0.16%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-32.68%
Min EPS beat(2)-198.04%
Max EPS beat(2)132.68%
EPS beat(4)1
Avg EPS beat(4)-41.91%
Min EPS beat(4)-198.04%
Max EPS beat(4)132.68%
EPS beat(8)1
Avg EPS beat(8)-36.68%
EPS beat(12)2
Avg EPS beat(12)-53.76%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.38%
Min Revenue beat(2)2.32%
Max Revenue beat(2)12.45%
Revenue beat(4)2
Avg Revenue beat(4)2.33%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)12.45%
Revenue beat(8)3
Avg Revenue beat(8)-0.01%
Revenue beat(12)6
Avg Revenue beat(12)9.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.8
P/S 0.63
P/FCF N/A
P/OCF 120.8
P/B 1.96
P/tB N/A
EV/EBITDA 13.82
EPS(TTM)-0.12
EYN/A
EPS(NY)0.28
Fwd EY6.33%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.04
OCFY0.83%
SpS6.86
BVpS2.21
TBVpS-1.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.48%
ROE -33.22%
ROCE 1.24%
ROIC 0.94%
ROICexc 1.09%
ROICexgc 5.13%
OM 1.07%
PM (TTM) N/A
GM 27.45%
FCFM N/A
ROA(3y)-5.38%
ROA(5y)-8.38%
ROE(3y)-15.9%
ROE(5y)-17.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.52%
GM growth 5Y-1.06%
F-Score4
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA 5.39
Cap/Depr 69.16%
Cap/Sales 3.51%
Interest Coverage 0.41
Cash Conversion 8.54%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.25
Altman-Z 2.03
F-Score4
WACC12.64%
ROIC/WACC0.07
Cap/Depr(3y)61.78%
Cap/Depr(5y)65.94%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
EPS Next Y329.5%
EPS Next 2Y78.61%
EPS Next 3Y51.03%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%58.63%
Revenue Next Year13.32%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1349.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.83%
OCF growth 3YN/A
OCF growth 5YN/A

LESAKA TECHNOLOGIES INC / LSAK FAQ

Can you provide the ChartMill fundamental rating for LESAKA TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 2 / 10 to LSAK.


Can you provide the valuation status for LESAKA TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 4 / 10 to LESAKA TECHNOLOGIES INC (LSAK). This can be considered as Fairly Valued.


How profitable is LESAKA TECHNOLOGIES INC (LSAK) stock?

LESAKA TECHNOLOGIES INC (LSAK) has a profitability rating of 1 / 10.


Can you provide the financial health for LSAK stock?

The financial health rating of LESAKA TECHNOLOGIES INC (LSAK) is 3 / 10.


What is the expected EPS growth for LESAKA TECHNOLOGIES INC (LSAK) stock?

The Earnings per Share (EPS) of LESAKA TECHNOLOGIES INC (LSAK) is expected to grow by 329.5% in the next year.